Featured Research

from universities, journals, and other organizations

Walking Three Times Weekly Slows Decline From Peripheral Artery Disease

Date:
January 3, 2006
Source:
Northwestern University
Summary:
A study in the Jan. 3 issue of the Annals of Internal Medicine shows that walking three times a week, even in an unsupervised exercise program, can significantly improve walking ability and slow progression of peripheral artery disease which often causes leg pain because of impaired blood flow in the arteries.

A study in the Jan. 3 issue of the Annals of Internal Medicine shows that walking three times a week, even in an unsupervised exercise program, can significantly improve walking ability and slow progression of peripheral artery disease (PAD). PAD often causes leg pain because of impaired blood flow in the arteries.

The study of 417 men and women, conducted by researchers at Northwestern University Feinberg School of Medicine, indicates that those who walked for exercise three or more times per week had a significantly smaller average annual decline in walking distance and speed than those who walked one to two times per week.

The study was led by Mary McGrae McDermott, M.D., associate professor of medicine, division of general internal medicine, at the Feinberg School.

The researchers also found that only a small proportion of African-American study participants walked for exercise three or more times per week. Previous studies have shown that African-American patients with PAD have greater functional impairment than white patients. Additionally, the prevalence of PAD is higher in African-Americans than in white patients.

"Data from the study suggest that doctors should take steps to encourage African-American individuals to increase their frequency of walking exercise," McDermott said.

Approximately 20 percent of the elderly have PAD. Research has shown that PAD tends to worsen over time, but participation in regular physical rehabilitation programs that include supervised treadmill walking at least three times a week has been shown to improve walking performance and slow the progression of the disease.

However, many patients with PAD have difficulty attending a supervised exercise program because of cost or transportation problems.

Results of the Northwestern study suggest that unsupervised walking exercise, such as that performed at home, also slows progression of PAD.

The researchers tested participants' physical ability by measuring the distance they could walk in 6 minutes and by observing their ability to get up from a chair unassisted; how well they maintained balance in a standing position; and how fast they could walk over a short distance.

The researchers also asked participants how often they walked for exercise and how long each walking session lasted. Besides showing that self-directed walking for exercise at least three times a week slowed decline in ability to perform physical activities, the study found that participants with the worst PAD at the start of the study were the ones most likely to benefit from a regular self-directed walking program.

###

McDermott's collaborators on this study were from Northwestern University Feinberg School of Medicine; Evanston Northwestern Healthcare; the National Institute on Aging; and the University of California-San Diego.

The study was supported by grants from the National Heart, Lung, and Blood Institute (grant numbers R01-HL58099 and R01-HL64739) and by the National Center for Research Resources, National Institutes of Health (grant number RR-00048). Northwestern is conducting another clinical research study to determine whether regular exercise can improve leg and ankle functioning in participants with PAD. For information on the PAD study, call (312) 695-2394.


Story Source:

The above story is based on materials provided by Northwestern University. Note: Materials may be edited for content and length.


Cite This Page:

Northwestern University. "Walking Three Times Weekly Slows Decline From Peripheral Artery Disease." ScienceDaily. ScienceDaily, 3 January 2006. <www.sciencedaily.com/releases/2006/01/060103084250.htm>.
Northwestern University. (2006, January 3). Walking Three Times Weekly Slows Decline From Peripheral Artery Disease. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2006/01/060103084250.htm
Northwestern University. "Walking Three Times Weekly Slows Decline From Peripheral Artery Disease." ScienceDaily. www.sciencedaily.com/releases/2006/01/060103084250.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins